Abstract
The place conditioning paradigm was used to examine the reinforcing properties of diazepam. Rats were injeccted with diazepam (0.5–5.0 mg/kg, IP) and 30 min later were confined for 30 min to one side of a shuttle box, in which each of the two compartments had distinctive features. On alternate (control) days they received vehicle injections and were confined for 30 min to the opposite side. At almost all doses tested, diazepam produced place preference for the distinctive compartment that had been previously associated with the drug. Preference for the drug side developed regardless of whether diazepam was paired or unpaired with the least-preferred side, and regardless of whether testing was carried out in the undrugged or in the drugged state. The rats preferred the drug side over a novel compartment, but they did not change their initial preference for the side when diazepam was given after removal from the training box.
Animals injected with meprobamate (70 mg/kg, PO), a non-benzodiazepine anxiolytic, also developed conditioned preference for the drug side, comparable to that seen following cocaine hydrochloride (10 mg/kg, IP).
The diazepam (2.5 mg/kg)-induced place preference was antagonized by CGS 8216 (3 mg/kg, IP), picrotoxin (2 mg/kg, IP) and naloxone (0.8 mg/kg, SC), injected 3 min before and 15 and 20 min after diazepam respectively. Sodium valproate (200 mg/kg, IP) did not influence diazepam (1 mg/kg)-induced place preference. Sodium valproate by itself had marginal effects on place conditioning. Picrotoxin and naloxone, but not CGS 8816, produced place aversion which, in the case of picrotoxin, was due to state dependent learning. The results provide a clear indication that the place preference paradigm is valid as a test for evaluating appetitive properties of minor tranquilizers. They suggest that the rewarding effects of diazepam are mediated through central benzodiazepine receptors. Wheter GABA and/or endogenous opioid peptides are involved in the reinforcing properties of diazepam remains an open question.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Andrews PR, Johnston GAR (1979) GABA agonists and antagonists. Biochem Pharmacol 28:2697–2702
Bernard P, Bergen K, Sobiski R, Robson RD (1981) CGS 8216 (2-phenyl-pyrazolo-(4,3-c) quinolin-3(5H)-one). An orally effective benzodiazepine antagonist. Pharmacologist 23:150
Billingsley LM, Kubena KR (1978) The effect of naloxone and picrotoxin on the sedative and anticonflict effects of benzodiazepines. Life Sci 22:897–906
Caudarella M, Campbell KA, Milgram NW (1982) Differential effects of diazepam (Valium) on brain stimulation reward sites. Pharmacol Biochem Behav 16:17–21
Cooper SJ (1983) Benzodiazepine-opiate antagonist interactions in relation to feeding and drinking behaviour (minireview) Life Sci 32:1043–1051
Costa E, Guidotti A (1979) Molecular mechanisms in the receptor action of benzodiazepines. Ann Rev Pharmacol Toxicol 19:531–545
Duka Th, Cumin R, Haefely W, Herz A (1981) Naloxone blocks the effect of diazepam and meprobamate on conflict behaviour in rats. Pharmacol Biochem Behav 15:115–117
Findley JD, Robinson WW, Peregrino L (1972) Addiction to secobarbital and chlordiazepoxide in the rhesus monkey by means of a self-infusion preference procedure. Psychoparmacologia 26:91–114
Gerhardt S, Prowse J, Liebman JM (1982) Anxiolytic drugs selectively increase preferred duration of rewarding brain stimulation in a shuttle box. Pharmacol Biochem Behav 16:795–799
Griffiths RR, Ator NA (1982) Benzodiazepine self-administration in animals and humans: A comprehensive literature review. In: Benzodiazepines, Monograph Series, Health and Human Services Publication, U.S. Government Printing Office, Washington, DC
Griffiths RR, Bigelow GE, Liebson I, Kaliszak JE (1980) Drug preference in humans: Double-blind choice comparison of pentobarbital, diazepam and placebo. J Pharmacol Exp Ther 215:649–661
Griffiths RR, Lukas SE, Bradford LD, Brady JV, Snell JD (1981) Self-injection of barbiturates and benzodiazepines in Baboons. Psychopharmacology 75:101–108
Haefeley W (1983) The biological basis of benzodiazepine action. The benzodiazepines today-two decades of research and clinical experience. J Psychoact Drugs 15:19–39
Haefeley W, Bonetti EP, Burkard WP, Cumin R, Laurent JP, Möhler H, Pieri L, Pole P, Richards JG, Schaffner R, Scherschlicht R (1983) Benzodiazepine antagonists. In: Costa E (ed) The benzodiazepines-from molecular biology to clinical practice. Raven Press, New York pp 137–146
Harvey PKP (1976) Some aspects of the neurochemistry of Epilim. In: Legg NJ (ed) Clinical and pharmacological aspects off sodium valproate (Epilim) in the treatment of epilepsy. Turnbridge Wells: MCS Consultants pp 130–134
Haug T (1983) Neuropharmacological specificity of the diazepam stimulus complex: Effects of agonists and antagonists. Eur J Pharmacol 93:221–227
Haug T, Gotestam KG (1982) The diazepam stimulus complex: Specificity in a rat model. Eur J Pharmacol 80:225–230
Healey ML, Pickens RW (1983) Diazepam dose preference in humans. Pharmacol Biochem Behav 18:449–456
Herberg LJ, Williams SF (1983) Anti-conflict and depressant effects by GABA agonsits and antagonists, benzodiazepines and non-GABA-ergic anticonvulsants on self-stimulation and locomotor activity. Pharmacol Biochem Behav 19:625–633
Johanson CE (1978) Drugs as reinforcers. In: Blackman DE, Sanger DJ (eds) Contemporary research in behavioral pharmacology Plenum Press, New York, pp 325–390
Johanson JO, Jarbe TUC (1975) Diazepam as a discriminative cue: Its antagonism by bemegride. Eur J Pharmacol 30:372–375
Marks J (1978) The Benzodiazepines. University Park, Baltimore
Millan MJ, Duka Th (1981) Anxiolytic properties of opiates and endogenous opioid peptides and their relationship to the actions of benzodiazepines. Mod Probl Pharmacopsychiatry 17:123–141
Möhler H, Richards JG (1983) Receptors for anxiolytic drugs. In: Malick JB, Enna SJ, Yamamura HI (eds) Anxiolytics: neurochemical, behavioural and clinical perspectives. Raven Press, New York, pp 15–40
Mucha RF, Iversen SD (1984) Reinforcing properties of morphine and naloxone revealed by conditioned place preerences: a procedural examination. Psychopharmacology 82:241–247
Mucha RF, van der Kooy D, O'Shaugnessy M, Bucenieks P (1982) Drug reinforcement studied in rat using place conditioning. Brain Res 243:91–105
Nielsen EB, Valentine JD, Holohean AM, Appel JB (1983) Benzodiazepine receptor mediated discriminative cues: Effects of GABA-ergic drugs and inverse agonsits. Life Sci 33:2213–2220
Olds ME (1966) Facilitatory action of diazepam and chlordiazepoxide on hypothalamic reward behaviour. J Comp Physiol Psychol 62:136–140
Rickels K (1981) Benzodiazepines: use and misuse. In: Klein DF, Rabkin JG (eds) Anxiety: New research and changing concepts. Raven Press, New York, pp 1–26
Sawynok J, Pinsky C, LaBella FS (1979) Minireview on the specificity of naloxone as an opiate antagonist. Life Sci 25:1621–1632
Shannon EH, Davis SL (1984) CGS 8216 noncompetitively antagonized the discriminative effects of diazepam in rats. Life Sci 34:2589–2596
Shannon EH, Herling S (1983) Discriminative stimulus effects of diazepam in rats: evidence for a maximal effect. J Pharmacol Exp Ther 227:160–166
Shearman GT, Millan MJ, Herz A (1982) Lack of evidence for a role of endorphinergic mechanisms in mediating a discriminative stimulus produced by diazepam in rats. Psychopharmacology 78:282–284
Sherman JE, Hickis CF, Rice AG, Rusiniak KW, Garcia J (1983) Preferences and aversions for stimuli paired with ethanol in hungry rats. Anim Learn Behav 11:101–106
Sherman JE, Pickman C, Rice A, Liebeskind JC, Holman EW (1980a) Rewarding and aversie effects of morphine: Temporal and pharmacological properties. Pharmacol Biochem Behav 13:501–503
Sherman JE, Roberts T, Roskam SE, Holman EW (1980b) Temporal properties of rewarding and aversive effects of amphetamine in rats. Pharmacol Biochem Behav 13:597–599
Soubrié PA, Jobert A, Thiébot MH (1980) Differential effects of naloxone against the diazepam-induced release of behavior in rats in three aversive situations. Psychopharmacology 69:101–105
Spyraki C, Fibiger HC, Phillips AG (1982a) Dopaminergic substrates of amphetamine-induced place preference conditioning. Brain Res 253:185–193
Spyraki C, Fibiger HC, Phillips AG (1982b) Cocaine-induced place preference conditioning: Lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res 253:195–203
Spyraki C, Fibiger HC, Phillips AG (1982c) Attenuation by haloperidol of place preference conditioning using food reinforcement. Psychopharmacology 77:379–382
Spyraki C, Fibiger HC, Phillips AG (1983) Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system. Psychopharmacology 79:278–283
Study RE, Barker JL (1982) Cellular mechanisms of benzodiazepine action. JAMA 247:2147–2151
Yanagita T, Takahashi S (1973) Dependence liability of several sedative-hypnotic agents evaluated in monkeys. J Pharmacol Exp Ther 185:307–316
Yokoyama N, Ritter B, Neubert AP (1982) 2-Arylpyrazolo (4,3-c) quinolin-3-ones. Novel. Agonist, partial agonist and antagonist of benzodiazepines. J Med Chem 25:337–339
Zbinden G, Randall LO (1967) Pharmacology off benzodiazepines: Laboratory and Clinical Correlations. Adv Pharmacol 5:213–292
Author information
Authors and Affiliations
Additional information
A preliminary report of this research was made at the 14 C.I.N.P. Congress (Florence 1984)
Rights and permissions
About this article
Cite this article
Spyraki, C., Kazandjian, A. & Varonos, D. Diazepam-induced place preference conditioning: Appetitive and antiaversive properties. Psychopharmacology 87, 225–232 (1985). https://doi.org/10.1007/BF00431813
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00431813